Italy Point-of-care Molecular Diagnostics Market Size & Outlook
The point-of-care molecular diagnostics market in Italy is expected to reach a projected revenue of US$ 245.0 million by 2030. A compound annual growth rate of 5.1% is expected of Italy point-of-care molecular diagnostics market from 2024 to 2030.
Revenue, 2023 (US$M)
$173.0
Forecast, 2030 (US$M)
$245.0
CAGR, 2024 - 2030
5.1%
Report Coverage
Italy
Italy point-of-care molecular diagnostics market, 2018-2030 (US$M)
Related Markets
Italy point-of-care molecular diagnostics market highlights
- The Italy point-of-care molecular diagnostics market generated a revenue of USD 173.0 million in 2023 and is expected to reach USD 245.0 million by 2030.
- The Italy market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
- In terms of segment, infectious diseases was the largest revenue generating application in 2023.
- Oncology is the most lucrative application segment registering the fastest growth during the forecast period.
Point-of-care molecular diagnostics market data book summary
| Market revenue in 2023 | USD 173.0 million |
| Market revenue in 2030 | USD 245.0 million |
| Growth rate | 5.1% (CAGR from 2023 to 2030) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Oncology |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
| Key market players worldwide | Roche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis |
Other key industry trends
- In terms of revenue, Italy accounted for 3.3% of the global point-of-care molecular diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany point-of-care molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 167.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Point-of-Care Molecular Diagnostics Market Scope
Point-of-care molecular diagnostics market segmentation & scope
Others
Point-of-Care Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy point-of-care molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.58% in 2023. Horizon Databook has segmented the Italy point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
- Italy Point-of-Care Molecular Diagnostics Application Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Prenatal Testing
- Endocrinology
- Other Applications
- Hematology
- Complete blood count (CBC)
- Prothrombin time (PT)
- Partial Thromboplastin Time (PTT)
- Others
- Infectious Diseases
- CT/NG
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and drug-resistant TB POC
- HSV POC
- COVID-19
- Other Infectious Diseases
- Italy Point-of-Care Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018-2030)
- PCR-based
- Genetic Sequencing based
- Hybridization based
- Microarray based
- Italy Point-of-Care Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2018-2030)
- OTC
- POC
- Italy Point-of-Care Molecular Diagnostics End Use Outlook (Revenue, USD Million, 2018-2030)
- Decentralised Labs
- Hospitals
- Home care
- Assisted Living Healthcare Facilities
- Others
Reasons to subscribe to Italy point-of-care molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy point-of-care molecular diagnostics market databook
-
Our clientele includes a mix of point-of-care molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Italy point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy point-of-care molecular diagnostics market size, by application, 2018-2030 (US$M)
Italy Point-of-Care Molecular Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
